Waltz to Serve on NIH Study Section
Susan Waltz, PhD, professor of cancer biology and member of both the Cincinnati Cancer Center and the UC Cancer Institute, has been asked to serve on the Cancer Molecular Pathology Study Section for the National Institutes of Health, for the term beginning July 1, 2014 and ending June 30, 2020.
The Cancer Molecular Pathobiology [CAMP] Study Section reviews applications involving the pathology of the malignant cell with the emphasis on mechanisms controlling cell growth and death, and the molecular events in gene regulation.
Emphasis is on pathological approaches to oncogenesis and the basic cellular events involving growth of transformed cells in animal models, with more translational studies in human cells.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.